Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial.

Ulf-Henrik Mellqvist Mellqvist, Jan Westin, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Inge Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Olle Linder, Hareth NahiIngerid Nesthus, Nielsaage Tøffner Clausen, Raija Silvennoinen, Niels Frost Andersen, Ingemar Turesson, Anders Waage

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

OriginalsprogEngelsk
TidsskriftBlood
ISSN0006-4971
StatusUdgivet - 2009
Udgivet eksterntJa
BegivenhedASH Annual Meeting -
Varighed: 5 dec. 20098 dec. 2009

Konference

KonferenceASH Annual Meeting
Periode05/12/200908/12/2009

Bibliografisk note

Udgivelsesdato: Nov 2009 Volumne: 114

Citationsformater